Get the Stockscreener App
3.98
3.11%
0.12
Lantern Pharma Inc stock is traded at $3.98, with a volume of 20,506.
It is up +3.11% in the last 24 hours and up +35.37% over the past month.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
See More
Previous Close:
$3.86
Open:
$3.91
24h Volume:
20,506
Relative Volume:
0.46
Market Cap:
$38.18M
Revenue:
-
Net Income/Loss:
$-19.09M
P/E Ratio:
-2.236
EPS:
-1.78
Net Cash Flow:
$-17.24M
1W Performance:
+12.43%
1M Performance:
+35.37%
6M Performance:
+3.65%
1Y Performance:
-41.56%
1-Day Range:
$3.8522
$4.05
1-Week Range:
$3.55
$4.4336
52-Week Range:
$2.55
$6.81
Lantern Pharma Inc Stock (LTRN) Company Profile
Name
Lantern Pharma Inc
Sector
Industry
Phone
972-277-1136
Address
1920 MCKINNEY AVENUE, DALLAS, TX
Compare LTRN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LTRN
Lantern Pharma Inc
|
3.98 | 38.18M | 0 | -19.09M | -17.24M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Lantern Pharma Inc Stock (LTRN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-07-21 | Initiated | H.C. Wainwright | Buy |
Lantern Pharma Inc Stock (LTRN) Latest News
Lantern Pharma to Report First Quarter 2025 Operating & Financial Results on May 15th, 2025 at 9:00 a.m. ET - BioSpace
Lantern Pharma to Report First Quarter 2025 Operating & Financial Results on May 15th, 2025 at 9:00 a.m. ET | LTRN Stock News - GuruFocus
Ion Pure Review: Is IonPure The Best Air Purifier Of 2025? - Barchart.com
Soybeans Continue Slide On Tuesday - Barchart.com
Pastor Ryan Macdonald Shares His Journey of Faith and Leadership in Exclusive Online Interview - Barchart.com
Entrepreneur Brandon Erickson From Wisconsin Featured In Exclusive Interview Spotlight - Barchart.com
Thinkific Announces First Quarter 2025 Financial Results - Barchart.com
Maneskin Store Launches 2025 Summer Collection For Rock Fans Worldwide - Barchart.com
OSC Analysis Highlights Increasing Mentions And Diverging Sentiment In AI Disclosures - Barchart.com
Cotton Lower At Midday - Barchart.com
Mining Companies Recognized For Excellence In Responsible Mining - Barchart.com
No Bull | The Five Spot - Barchart.com
LTRN: IND Clearance for LP-184 in TNBC - MSN
East Side Games Group To Announce First Quarter 2025 Financial Results - Barchart.com
Cotton Pushing Back Lower On Tuesday Morning - Barchart.com
Bell Unveils Tech Services Brand Ateko, Merging Three Recently Acquired Companies - Barchart.com
Natural Gas Slowed Down For A Correction Within Uptrend - Barchart.com
IBM Accelerates Enterprise Gen AI Revolution With Hybrid Capabilities - Barchart.com
2 Reasons To Like S And 1 To Stay Skeptical - Barchart.com
Lantern Advances Drug Candidate LP-184 with IND Clearance for Ph - GuruFocus
Lantern Pharma (LTRN) Gains FDA Approval for Clinical Trial in B - GuruFocus
Corn Collapses Towards April Lows On Monday - Barchart.com
Car Haggle Helper Launches No-Risk Service That Saves New Car Buyers $4 – $8K on Average - Barchart.com
Lucintel Forecasts The Global MRD Testing Market To Reach $3.4 Billion By 2031 - Barchart.com
Wellesley Homes Get A Touch Of Glam With IDEAL Showers - Barchart.com
Powersolv, Inc. Announces Headquarters Relocation To Montgomery County, Maryland - Barchart.com
Dollar Moves Lower And Gold Rallies On US Trade Uncertainty - Barchart.com
Recovery Support In Muskoka: A Closer Look At Rehabilitation Services In Ontario - Barchart.com
Corn Pressured At Midday With Double Digit Losses - Barchart.com
Lantern Advances Drug Candidate LP-184 with IND Clearance for Phase 1b/2 Clinical Trial in Triple Negative Breast Cancer (TNBC) - 01net
Avizle Launches New Platform To Streamline Visa Applications For Indian Travelers - Barchart.com
Lantern Pharma (LTRN) Gets FDA Green Light to Begin Human Trials for New Breast Cancer Drug - Barchart.com
Florida Jury Awards Man $3M For Defective Airbag That Caused Serious Injury During Crash - Barchart.com
Lantern Pharma (LTRN) Gains FDA Approval for Clinical Trial in Breast Cancer | LTRN Stock News - GuruFocus
Cattle Look To New Week, After A Week Of Cash Strength - Barchart.com
Lantern Pharma Inc expected to post a loss of 49 cents a shareEarnings Preview - TradingView
AgJunction Sets Third Quarter 2021 Conference Call for Monday, November 15, 2021, at 11:00 a.m. ET - Barchart.com
Elon Musk’s rocket launch site Starbase on its way to becoming a Texas city after lopsided early voting results - Barchart.com
The Ventures Award Expands Global Presence In 2025, Spotlighting Excellence In Early-Stage Innovation - Barchart.com
Katharina Muller Drives AI Financial Innovation - Barchart.com
Tech Weakness Meets Trade Optimism—Will Bulls Regain Control? - Barchart.com
COFOMO WELCOMES EPERFORMANCE TO ITS TEAM - Barchart.com
Plaque To Mark Safe Return Of 'Lucky 7' Newfoundland Fishers After Days Adrift At Sea - Barchart.com
RCMP In Eastern Newfoundland Take Over Search For Pilot Of Downed Small Plane - Barchart.com
McDonald's store traffic falls unexpectedly to start the year as diners grow increasingly uneasy over the economy - Barchart.com
Moderna: Q1 Earnings Snapshot - Barchart.com
Lantern Pharma (LTRN) to Release Quarterly Earnings on Thursday - Defense World
STATEMENTCMA Marks National Physicians' Day - Barchart.com
What You Need To Know Ahead Of McCormick & Company's Earnings Release - Barchart.com
Hogs Fall Weaker On Wednesday - Barchart.com
This Company Extended Its Post-Earnings Rally To Record Highs - Barchart.com
Lantern Pharma Inc Stock (LTRN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lantern Pharma Inc Stock (LTRN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Fletcher Aaron G.L. | 10% Owner |
May 23 '24 |
Sale |
6.25 |
10,000 |
62,500 |
59,326 |
0.84%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):